About Careers Internship MedBlog Contact us

Cell Response to Novel Human Coronavirus Opens Possible Paths to Treatments

by Bidita Debnath on May 5, 2013 at 4:52 PM
 Cell Response to Novel Human Coronavirus Opens Possible Paths to Treatments

WHAT:To study the cells' response to infection by a novel human coronavirus (called nCoV), NIH-supported scientists used lab-grown human lung cells.

And they compiled the information about which genes are significantly disrupted in xearly and late stages of infection. The information about host response to nCoV allowed the researchers to predict drugs that might be used to inhibit either the virus itself or the deleterious responses that host cells make in reaction to infection. Since nCoV was recognized in 2012, 17 confirmed cases and 11 deaths have been reported—a high fatality rate that is spurring urgent research efforts to better understand the virus and its effects.


The investigators, led by Michael G. Katze, Ph.D., of the University of Washington, compared cellular gene expression responses to two viruses: the novel coronavirus and a coronavirus that caused a global outbreak of severe acute respiratory syndrome (SARS) in 2003. Although the viruses are in the same family, their effects on human cells are vastly different. In general, nCoV disrupted a greater number of human genes more profoundly and at more time points after infection than the SARS coronavirus. The team identified one set of 207 human genes whose expression differed from normal soon after infection with nCoV and remained disrupted throughout the course of infection. Notably, nCoV down-regulated the activity of a group of genes involved in signaling the presence of an invading virus to the immune system. Such down-regulation may cause a delay in the infection-fighting response.

The researchers used computational approaches to determine that certain classes of drugs, including specific kinase inhibitors and one type of glucocorticoid, act on some of the 207 human genes whose expression was found to be disrupted by nCoV. The team hypothesized that treatment with such drugs might block nCoV replication and disease progression in the host. In their current study, they tested this hypothesis using a kinase inhibitor on nCoV-infected cells grown in test tubes. They found that the drug did inhibit the ability of the virus to replicate. Additional studies are needed to see if kinase inhibitors could be useful alone or in combination with other drugs to treat nCoV infection in people.

ARTICLE:L Josset et al. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. mBio DOI: 10.1128/mBio.00165-13 (2013) http://mbio.asm.org/content/4/3/e00165-13.

WHO:Valentina Di Francesco, program officer, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, is available to discuss this research.

Source: Eurekalert
Font : A-A+



Recommended Readings

Latest Coronavirus News

STRIVE Consortium's Quest to Tame the Immune Storm
Clinical trial to evaluate the immune modulation approach for hospitalized COVID-19 patients kicks off to investigate the potential benefits of immune modulation.
Free At-Home COVID-19 Test Kits Return to US on September 25th
Free at-home coronavirus tests were initially distributed to Americans via the Postal Service in early 2022, in response to the surge in Omicron cases.
Tau Proteins: Key Players in Understanding COVID-19 Brain Fog
In Alzheimer's disease patients, COVID-19 infection may exacerbate cognitive symptoms, including brain fog.
Early Convalescent Plasma Use May Reduce Severe COVID and Long COVID Risk
COVID-19 patients receiving early convalescent plasma treatment are less likely to develop post-COVID (long COVID) with SARS-CoV-2 antibodies.
The Return of Masks and Lockdowns
Discussions gain traction on the resurgence of masks and limited lockdowns this winter amid rising COVID variants.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Cell Response to Novel Human Coronavirus Opens Possible Paths to Treatments Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests